SMART-CHOICE 3 Trial Insights | JACC: Asia Pulse

26 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In this Peer Perspectives interview, JACC: Asia Pulse Content Editor, Jeehoon Kang, MD and Joo-Yong Hahn, MD, PhD discuss the key findings and clinical relevance of the SMART-CHOICE 3 trial. The study evaluated clopidogrel versus aspirin monotherapy following standard-duration dual antiplatelet therapy (DAPT) in high-risk patients undergoing PCI with contemporary drug-eluting stents. Hear expert commentary on the trial’s design, outcomes, and its potential to reshape antithrombotic strategies in interventional cardiology. #jaccasia #accintl #dapt #pci #clopidogrel #aspirin

Additional Information:
https://www.jacc.org/jacc-asia/pulse
https://www.jacc.org/journal/jacc-asia
Categoria
Cardiology
Commenta per primo questo video.

Prossimo